MENU
CH | CHF
-
-
-
-
- Forum Labo 2025
- Advanced Therapies Week (ATW) 2025
- SLAS Europe 2025
- Bioprocessing Summit Europe 2025
- Medlab Middle East 2025
- SLAS International 2025
- Biologics World Nordics 2025
- ASIA LABEX: The Lab Show 2025
- BioProcess International Europe 2025
- ISEV 2025
- Future Labs Live 2025
- DataHow Symposium 2025
- Cell 2025
- ASIA LABEX: The Lab Show 2025
- LabDays 2025
- ILMAC 2025
- Stem Cell Community Day 2025
- Nordic Life Science Days 2025
- JASIS 2025
-
-
-
-
- Forum Labo 2025
- Advanced Therapies Week (ATW) 2025
- SLAS Europe 2025
- Bioprocessing Summit Europe 2025
- Medlab Middle East 2025
- SLAS International 2025
- Biologics World Nordics 2025
- ASIA LABEX: The Lab Show 2025
- BioProcess International Europe 2025
- ISEV 2025
- Future Labs Live 2025
- DataHow Symposium 2025
- Cell 2025
- ASIA LABEX: The Lab Show 2025
- LabDays 2025
- ILMAC 2025
- Stem Cell Community Day 2025
- Nordic Life Science Days 2025
- JASIS 2025
CH | CHF
-
- Toutes les centrifugeuses
- Centrifugeuses de paillasse
- Centrifugeuses au sol
- Centrifugeuses réfrigérées
- Microcentrifugeuses
- Centrifugeuses multi-fonctions
- Centrifugeuses haute vitesse
- Ultracentrifugeuses
- Concentrateur
- Produits IVD
- High-Speed and Ultracentrifuge Consumables
- Tubes de centrifugeuse
- Plaques de centrifugeuse
- Gestion des appareils
- Gestion des échantillons et des informations
-
- Toutes les pipettes, tous les distributeurs et tous les systèmes automatisés de manipulation de liquides
- Pipettes mécaniques
- Pipettes électroniques
- Pipettes multicanaux
- Distributeurs et pipettes à déplacement positif
- Pointes de pipette
- Distributeurs sur flacon
- Auxiliaires de pipetage
- Accessoires pour pipettes et distributeurs
- Automates de pipetage
- Consommables d’automatisation
- Accessoires d’automatisation
- Services pour pipettes et distributeurs
Sorry, we couldn't find anything on our website containing your search term.
Sorry, we couldn't find anything on our website containing your search term.
Vaccine Research Discovered
Well thought-out tools for pharmaceutical and biotech laboratories
Read more
Read less
STRONG GROWING VACCINES
Protein subunit vaccines
Protein subunit vaccines (e.g., for influenza, hepatitis B and C) are a proven strategy for decades and still today in the spotlight for pandemic management.
➕ Require no production of the whole pathogen because the vaccine consists of immunogenic viral or bacterial fragments generated by recombinant protein techniques. Since non-pathogenic, they are considered as safe. Multiple expression systems for antigenic protein components such as yeast, bacteria, insect, mammalian, and plant cells, allow the production of large quantities and to address unmet needs.
➖ Establishment of a proper scale-up of antigen production can be a major constraint. Several booster doses and adjuvants are needed.
Protein subunit vaccines (e.g., for influenza, hepatitis B and C) are a proven strategy for decades and still today in the spotlight for pandemic management.
➕ Require no production of the whole pathogen because the vaccine consists of immunogenic viral or bacterial fragments generated by recombinant protein techniques. Since non-pathogenic, they are considered as safe. Multiple expression systems for antigenic protein components such as yeast, bacteria, insect, mammalian, and plant cells, allow the production of large quantities and to address unmet needs.
➖ Establishment of a proper scale-up of antigen production can be a major constraint. Several booster doses and adjuvants are needed.
Virus-like particle vaccines
Virus-like particle vaccines are self-assembled viral structural proteins that mimic the native virus. This feature enables to trigger strong immune responses.
➕ Lacking the viral genome, the safety profile is excellent. The production is scalable and safe as no living virus or inactivation steps are involved.
➖ The particle assembly is sometimes challenging, the manufacturing process complicated.
Virus-like particle vaccines are self-assembled viral structural proteins that mimic the native virus. This feature enables to trigger strong immune responses.
➕ Lacking the viral genome, the safety profile is excellent. The production is scalable and safe as no living virus or inactivation steps are involved.
➖ The particle assembly is sometimes challenging, the manufacturing process complicated.
IMPROVE YOUR RECOMBINANT PROTEIN VACCINE DISCOVERY
*All products are for Research Use Only (RUO).